Physician profile
Dawn M Gary
NPI 1780770487
$985.31
in general payments reported to CMS, 2019-2025
14 companies · $94.74 in 2025
The $94.74 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $79.82 · 2021: $14.46 · 2022: $105 · 2023: $291 · 2024: $224 · 2025: $94.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $253.43 | 2024-2025 | Qelbree |
| Tris Pharma INC | $191.40 | 2019-2024 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $153.20 | 2019-2023 | Bexsero, Pediarix |
| Ironshore Pharmaceuticals INC. | $63.38 | 2019-2023 | Jornay Pm |
| Merck Sharp & Dohme LLC | $62.89 | 2022-2024 | M-M-R II, Gardasil 9, Vaxelis |
| Vertical Pharmaceuticals, LLC | $58.07 | 2019 | |
| Pfizer INC. | $50.04 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.95 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $31.86 | 2024 | |
| Sobi, INC | $20.34 | 2019 | |
| Adlon Therapeutics L.P. | $15.87 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $14.70 | 2022 | |
| Phadia US INC. | $12.84 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Gary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.